Dupixent is alleged to cause or accelerate Cutaneous T-cell Lymphoma (“CTCL”) which is a rare and serious white blood cell cancer. Dupixent is prescribed for atopic dermatitis, eczema, asthma and other allergic conditions, including: nasal polyps/chronic sinusitis, eosinophilic esophagitis, prurigo nodularis and chronic obstructive pulmonary disease “(“COPD”). Dupixent acts to mask or accelerat…
Read moreJuul has been aggressively marketing its Vape Pens to teenage consumers nationwide; often with the sales pitch of being a safe alternative to smoking cigarettes. However, these Vape Pens, along with e-cigarettes, have been found potentially fatal and pose numerous health risks.
It is well established that nicotine consumption has immeasurable health risks and smoking tobacco is a leading cau…
Read moreAccording to the FDA, pathological gambling, binge eating, hyper-sexuality and compulsive shopping are all known side-effects linked to the prescription medication ABILIFY.
Abilify is an anti-psychotic drug developed by Otsuka Pharmaceutical Co., LTD and Otsuka America Pharmaceutical, Inc. It entered the US market in 2002 after co-opting its development and commercialization with the well-kn…
Read more